Haleon (XTER:H6D0) Other Long-Term Liabilities : €0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Other Long-Term Liabilities?

Haleon's other long-term liabilities for the quarter that ended in Mar. 2024 was €0 Mil.

Haleon's quarterly other long-term liabilities increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€4,328 Mil) but then declined from Dec. 2023 (€4,328 Mil) to Mar. 2024 (€0 Mil).

Haleon's annual other long-term liabilities increased from Dec. 2021 (€3,993 Mil) to Dec. 2022 (€4,397 Mil) but then declined from Dec. 2022 (€4,397 Mil) to Dec. 2023 (€4,328 Mil).

Haleon Other Long-Term Liabilities Historical Data

The historical data trend for Haleon's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Other Long-Term Liabilities Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

Haleon Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Haleon Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Haleon's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (XTER:H6D0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (XTER:H6D0) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK HLN:UK

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon (XTER:H6D0) Headlines

No Headlines